Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04GJN
|
||||
| Former ID |
DAP000861
|
||||
| Drug Name |
Megestrol
|
||||
| Synonyms |
Chronopil; Megestrolo; Megestrolo [DCIT]; Chronopil (TN); Megace (TN); Megestrol (INN); Megestrol [INN:BAN]; Megestrolum [INN-Latin]; (8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one; 17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Advanced breast carcinoma; Advanced endometrium carcinoma [ICD9: 174, 175, 182.0; ICD10:C50, C54.1] | Approved | [536165] | ||
| Therapeutic Class |
Anticancer Agents
|
||||
| Company |
Bristol Myers Squibb
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C22H30O3
|
||||
| Canonical SMILES |
CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
|
||||
| InChI |
1S/C22H30O3/c1-13-11-16-17(20(3)8-5-15(24)12-19(13)20)6-9-21(4)18(16)7-10-22(21,25)14(2)23/h11-12,16-18,25H,5-10H2,1-4H3/t16-,17+,18+,20-,21+,22+/m1/s1
|
||||
| InChIKey |
VXIMPSPISRVBPZ-NWUMPJBXSA-N
|
||||
| CAS Number |
CAS 3562-63-8
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| ChEBI ID |
ChEBI:6722
|
||||
| SuperDrug ATC ID |
G03AC05; G03DB02; L02AB01
|
||||
| SuperDrug CAS ID |
cas=003562638
|
||||
| Target and Pathway | |||||
| Target(s) | Progesterone receptor | Target Info | Binder | [535883] | |
| KEGG Pathway | Oocyte meiosis | ||||
| Progesterone-mediated oocyte maturation | |||||
| Pathway Interaction Database | Cellular roles of Anthrax toxin | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.